Revenio Group Oyj - Annual Financial Report

Revenio Group Corporation: Revenio Group Corporation publishes Annual Report 2015

Revenio Group Corporation, Stock Exchange Release, February 23, 2015 at 13:40

REVENIO GROUP CORPORATION PUBLISHES ANNUAL REPORT 2015

Today, Revenio Group Corporation published the annual report for 2015. The AR,
available in Finnish in PDF format on the corporations' website at
www.revenio.fi, contains financial statements for the corporation and parent
company, the report of the Board of Directors, auditors report and a report on
corporate governance.

The AR will be published in print in week 11. To order a copy, place an order
with Revenio Group Corporation, Äyritie 22, FI-01510 Vantaa, tel.
+358 50 382 0131 or by e-mail elina.kari@revenio.fi.

Revenio Group Corporation
Olli-Pekka Salovaara
President and CEO

For further information, please contact:
President & CEO Olli-Pekka Salovaara, tel. +358 40 567 5520
olli-pekka.salovaara@revenio.fi
www.revenio.fi

DISTRIBUTION:
NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media
www.revenio.fi

The Revenio Group in brief

Revenio is a Finnish, globally operating health technology corporation whose
worldwide success is based on a strongly patented intraocular pressure
measurement technology. The Revenio Group consists of Icare Finland Oy, Revenio
Research Oy and Oscare Medical Oy, in which Revenio holds a 53% interest. The
common denominators of Revenio's business operations include screening, follow-
up and the global need to make cost savings through preventive health care.
Revenio seeks vigorous growth in health technology. Revenio aims at developing
even more efficient and easily adopted methods for the early-stage detection of
diseases with significance for public health. The focus of Revenio's screening
technology is on the early detection of glaucoma, osteoporosis, skin cancer and
asthma, and the monitoring of these during the treatment process.

In 2015, the Revenio Group's net sales totaled MEUR 20.3, with its operating
margin for continuing operations standing at 28.4%. Revenio Group Corporation is
listed on Nasdaq Helsinki.

[HUG#1988336]

Viðhengi:

Revenio_Group_Corporate_Governance_2015_EN.pdf

Revenio_Group_Corporation_Annual_Report_2015.pdf